ConductScience.org, home

Gene · 1460

CSNK2B: casein kinase 2 beta

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CSNK2B: casein kinase 2 beta. Genes, record 1460. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1460

On this page

Gene

Symbol
CSNK2B
HGNC
Name
casein kinase 2 beta
HGNC
NCBI Gene ID
1460
NCBI Gene
HGNC ID
HGNC:2460
HGNC
Ensembl
ENSG00000204435
NCBI Gene
Aliases
CK II beta, CK2B, CK2N, CSK2B, Ckb1, Ckb2, G5A, POBINDS
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P67870Casein kinase II subunit beta21510Ensembl, GeneID, HGNC

Source UniProt

Patents202

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProtein
JP 2026004568 A2026-01-1440179P67870
JP 2026004568 A2026-01-1440180P67870
JP 2026004568 A2026-01-1440181P67870
JP 2026004568 A2026-01-1440182P67870
JP 2026004568 A2026-01-1440184P67870
JP 2026004568 A2026-01-1440185P67870
JP 2026004568 A2026-01-1440187P67870
JP 2026004568 A2026-01-1440190P67870
JP 2026004568 A2026-01-1440192P67870
JP 2026004568 A2026-01-1440195P67870

1 to 10 of 202Source Espacenet

See all 202 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants998

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCSNK2B papersNewest fiscal year
P30CA008748Cancer Center Support Grant42025
P30CA016672Cancer Center Support Grant42025
P30CA076292Moffitt Cancer Center Support Grant32025
P30CA077598Cancer Center Support Grant32025
P40OD010440Caenorhabditis Genetics Center32025
R35GM122481Development and Testing of New Computational Methods for Ligand Discovery and Mechanism32025
U19AI135972SARS-CoV adaptations through a Systems Biology Lens (SYBIL)32025
U19AI135990HPMI: Host Pathogen Mapping Initiative32025
UL1TR002345Washington University Institute of Clinical and Translational Sciences32025
ZIANS002994Subunit-Specific Regulation Of Glutamate Receptors32025

1 to 10 of 998Source NIH's project files

See all 998 nih grants

Papers1,702

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Genomic Reanalysis of Neurodevelopmental Disorders With and Without Epilepsy: Diagnostic Yield and Mechanisms of Newly Established Diagnoses.Genes (Basel)202642792972PubTator, text miningPubMed
CSNK2B Expression Aligns with a GDF15-Associated Immune Molecular State in Hepatocellular Carcinoma.Biomedicines202642792651PubTator, text miningPubMed
SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.Sci Transl Med202642777084PubTator, text miningPubMed
CSNK2B-associated epilepsy: family report and literature review.Acta Epileptol202642764391PubTator, text miningPubMed
Profiling miRNAs Involved in Human Oligodendrocyte Precursor Cell Differentiation and Maturation.Cells202642587753PubTator, text miningPubMed
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme.RSC Chem Biol202642433702PubTator, text miningPubMed
A Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Susceptibility Genes for Glomerular Diseases.Biomedicines202642193397PubTator, text miningPubMed
Functional characterization of 42 CK2α de novo variants associated with Okur-Chung neurodevelopmental syndrome.FEBS J202641978434PubTator, text miningPubMed
Dravet Syndrome Associated With a CSNK2B-Related Neurodevelopmental Disorder.Cureus202641890472PubTator, text miningPubMed
PACS1 syndrome mutation disrupts dynein-mediated cargo transport via HDAC6 and BICD2.Commun Biol202641888583PubTator, text miningPubMed

1 to 10 of 1,702

See all 1,702 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1460

GET https://conductscience.org/api/genes/v1/1460/patents?page=2